About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Obesity, Diabetes and Cancer Risk
By
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
FEATURING
Derek LeRoith
By
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
FEATURING
Derek LeRoith
0 views
June 16, 2017
Comments
0
Login to view comments.
Click here to Login
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
Featured Video
46:20
Lilly Diabetes
A Journey Through Clinical Efficacy and Safety Data Comparing Two In…
Feat.
S. Shadid
Recommended
AUTOPLAY
ON
Related
Newest
16:02
Masterclasses in Dermatology
Update on Benzene in Dermatology Products
Feat.
C. Bunick
06:00
2024 Clinical Case Studies
Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration
Feat.
A. Geisler
30:24
Balgrist University Hospital
Cervical Corpectomy and En Bloc Resection
Feat.
D. Rothenfluh
27:14
2024 Clinical Case Studies
Clinical Case Review: Cutaneous T Cell Lymphoma in the Patch Test Cl…
Feat.
J. Murase
13:16
ASH 2022 Conference Coverage
Experts Discuss Key Updates in CLL
Feat.
S. O'Brien,
C. Coombs
10:35
Alan Skarbnik
Learnings From the ELEVATE-TN Phase 3 Trial: Acalabrutinib+/-Obinutu…
04:14
ecancer
ALPINE: A Randomized Phase 3 Study of Zanubrutinib vs. Ibrutinib for…
Feat.
J. Brown
18:04
Seema Bhat
Zanubrutinib for the Treatment of CLL: Learnings From ALPINE, SEQUOI…
06:53
Fred Hutchinson Cancer Center
Surveying Safety and Efficacy Data in R/R CLL: ALPINE and ELEVATE-RR…
Feat.
M. Shadman
13:27
Benjamin Heyman
Recent Updates in CLL
16:43
Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient
Advances in CLL and Mantle Cell Lymphoma
Feat.
E. Chong
17:23
Current Challenges in Hematology
2023 Updates on Sequencing in CLL
Feat.
L. Scarfò
09:33
Adam Kittai
Chemo-Free Approaches in the Frontline Setting of CLL: Treatment Goa…
12:06
Catherine Coombs
New BTKi in CLL
24:11
Jennifer Brown
State of the Art & Next Questions: CLL
09:57
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "KRd vs. Elotuzumab + KRd in Transplant-El…
Feat.
S. Knop
14:21
Masterclasses in Dermatology
Comorbidities of Psoriasis and PsA
Feat.
J. Cohen
06:32
ASCO 2022 Conference Coverage
ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …
Feat.
S. Shen
67:23
University of Louisville
CAR T-Cell Therapy has Redefined the Treatment Algorithm for Relapse…
Feat.
M. Kharfan-Dabaja
09:33
City of Hope
Assessing Comorbidities in CLL
Feat.
A. Danilov
